Goldenwell Biotech IncOTCQB:GWLL
- LAST PRICE0.0586
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0586
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Goldenwell Biotech Inc | 5.8M | -48.0x | --- |
Enzon Pharmaceuticals Inc | 5.8M | 59.1x | -60.21% |
Avenue Therapeutics Inc | 5.9M | -0.1x | --- |
Actavia Life Sciences Inc | 6.0M | -1.0x | --- |
Burzynski Research Institute Inc | 5.5M | -4.6x | --- |
Mymd Pharmaceuticals Inc | 5.5M | -0.5x | --- |
Company Information
Goldenwell Biotech, Inc. is in the development stage whose purpose is research and development, production and sales health cares and supplements products. The Company is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide, Se Plus, and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence) which made from healthy and fresh bovine cardiac vascular tissues as raw materials. Its DPAG product is designed to be an easily absorbed bioactive collagen. Type II collagen peptide is prepared from Bovine or Pig Cartilage bones by hot water extraction. Its Sugar Master product is made utilizing low temperature extraction techniques to maximize the harvest of bio-actives of plant matter.
Contact Information
- Headquarters
- 581 Boston Mills Road, Suite 300HUDSON, OH, United States 44236
- Phone
- 440-666-7999
- Fax
- ---
Executives
- President, Chief Executive Officer, Director
- Shuang Liu
- Treasurer, Director
- Li Yang
- Secretary, Director
- Xie Hua
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.8M |
|---|---|
Revenue (TTM) | $2.3K |
Shares Outstanding | 99.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -48.0x |
Price/Sales (TTM) | 2,479.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,995.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
